US Patent 7943772 Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
Patent 7943772 was granted and assigned to Theravance on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+468 characters)
Article
Patent abstract
The invention provides a crystalline sulfate salt of 3-endo-(8-{2-[cyclohexylmethyl-((S)-2,3-dihydroxy-propionyl)amino]ethyl}-8-aza-bicyclo[3.2.1]oct-3-yl)benzamideor a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline salt forms.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Leticia M. Preza0
Miroslav Rapta0
Pierre-Jean Colson0
Sean Dalziel0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943772 Crystalline forms of an 8-azabicyclo(3.2.1)octane compound US Patent 7943772 Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
Infobox
Patent Number
079437720
Patent Number
79437720
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079437720
Date of Patent
May 17, 2011
0Patent Application Number
120725340
Date Filed
February 27, 2008
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07943772 Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07943772
Date of patent
May 17, 2011
Patent application number
12072534
Date Filed
February 27, 2008
Patent primary examiner
Find more entities like US Patent 7943772 Crystalline forms of an 8-azabicyclo(3.2.1)octane compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
